Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hashim U Ahmed

Showing results (41-50 of 273) with videos related to

Pageof 28
Sort By:
BJU International|October 17, 2012
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populationsMatthew R Hotston, Hashim U Ahmed, Rajendra Persad
Nature Reviews. Urology|July 25, 2022
The unclear role of PET-CT in localized radiorecurrent prostate cancerAlexander Light, Hashim U Ahmed, Taimur T Shah
JAMA Oncology|December 6, 2019
Survival in Oligometastatic Prostate Cancer-A New Dawn or the Will Rogers Phenomenon?Martin J Connor, Mathias Winkler, Hashim U Ahmed
BJU International|July 13, 2006
Nanotechnology: potential applications in urologyAthanasios Tsiouris, Hashim U Ahmed, Amir V Kaisary
Nature Reviews. Urology|August 18, 2016
Does true Gleason pattern 3 merit its cancer descriptor?Saiful Miah, Hashim U Ahmed, Alex Freeman, et al.
European Urology Oncology|January 22, 2021
Can Diagnostic Magnetic Resonance Imaging for Suspected Clinically Significant Prostate Cancer Predict Unfavorable Long-term Outcome for Diagnosed Men for Pretreatment Counseling?Ivo G Schoots, Hashim U Ahmed, Anwar R Padhani
BJU International|January 7, 2011
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatmentLucy Simmons, Hashim U Ahmed, Caroline Moore, et al.
The Lancet. Oncology|May 1, 2007
Molecular and genetic pathways in penile cancerOliver Kayes, Hashim U Ahmed, Manit Arya, et al.
Urology|February 19, 2022
TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate CancerPeter K F Chiu, Hashim U Ahmed, Ardeshir R Rastinehad
European Radiology|February 23, 2022
Assessing the clinical performance of artificial intelligence software for prostate cancer detection on MRITobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Pageof 28

Showing results (41-50 of 273) with videos related to

Sort By:
Pageof 28
BJU International|October 17, 2012
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populationsMatthew R Hotston, Hashim U Ahmed, Rajendra Persad
Nature Reviews. Urology|July 25, 2022
The unclear role of PET-CT in localized radiorecurrent prostate cancerAlexander Light, Hashim U Ahmed, Taimur T Shah
JAMA Oncology|December 6, 2019
Survival in Oligometastatic Prostate Cancer-A New Dawn or the Will Rogers Phenomenon?Martin J Connor, Mathias Winkler, Hashim U Ahmed
BJU International|July 13, 2006
Nanotechnology: potential applications in urologyAthanasios Tsiouris, Hashim U Ahmed, Amir V Kaisary
Nature Reviews. Urology|August 18, 2016
Does true Gleason pattern 3 merit its cancer descriptor?Saiful Miah, Hashim U Ahmed, Alex Freeman, et al.
European Urology Oncology|January 22, 2021
Can Diagnostic Magnetic Resonance Imaging for Suspected Clinically Significant Prostate Cancer Predict Unfavorable Long-term Outcome for Diagnosed Men for Pretreatment Counseling?Ivo G Schoots, Hashim U Ahmed, Anwar R Padhani
BJU International|January 7, 2011
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatmentLucy Simmons, Hashim U Ahmed, Caroline Moore, et al.
The Lancet. Oncology|May 1, 2007
Molecular and genetic pathways in penile cancerOliver Kayes, Hashim U Ahmed, Manit Arya, et al.
Urology|February 19, 2022
TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate CancerPeter K F Chiu, Hashim U Ahmed, Ardeshir R Rastinehad
European Radiology|February 23, 2022
Assessing the clinical performance of artificial intelligence software for prostate cancer detection on MRITobias Penzkofer, Anwar R Padhani, Baris Turkbey, et al.
Pageof 28